113 related articles for article (PubMed ID: 1715699)
1. Interleukin 8-inhibitor and inducer of histamine and leukotriene release in human basophils.
Bischoff SC; Baggiolini M; de Weck AL; Dahinden CA
Biochem Biophys Res Commun; 1991 Aug; 179(1):628-33. PubMed ID: 1715699
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists.
Bischoff SC; Brunner T; De Weck AL; Dahinden CA
J Exp Med; 1990 Dec; 172(6):1577-82. PubMed ID: 1701820
[TBL] [Abstract][Full Text] [Related]
3. Activation of human basophils through the IL-8 receptor.
Krieger M; Brunner T; Bischoff SC; von Tscharner V; Walz A; Moser B; Baggiolini M; Dahinden CA
J Immunol; 1992 Oct; 149(8):2662-7. PubMed ID: 1383321
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
Brunner T; de Weck AL; Dahinden CA
J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G
J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 3-dependent mediator release in basophils triggered by C5a.
Kurimoto Y; de Weck AL; Dahinden CA
J Exp Med; 1989 Aug; 170(2):467-79. PubMed ID: 2474054
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 and RANTES inhibit basophil histamine release induced with monocyte chemotactic and activating factor/monocyte chemoattractant peptide-1 and histamine releasing factor.
Alam R; Forsythe PA; Lett-Brown MA; Grant JA
Am J Respir Cell Mol Biol; 1992 Oct; 7(4):427-33. PubMed ID: 1382479
[TBL] [Abstract][Full Text] [Related]
8. The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils.
Dahinden CA; Kurimoto Y; De Weck AL; Lindley I; Dewald B; Baggiolini M
J Exp Med; 1989 Nov; 170(5):1787-92. PubMed ID: 2478657
[TBL] [Abstract][Full Text] [Related]
9. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3.
Kuna P; Reddigari SR; Kornfeld D; Kaplan AP
J Immunol; 1991 Sep; 147(6):1920-4. PubMed ID: 1716285
[TBL] [Abstract][Full Text] [Related]
10. Stimulus-dependent leukotriene release from human basophils: a comparative study of C5a and Fmet-leu-phe.
MacGlashan D; Warner J
J Leukoc Biol; 1991 Jan; 49(1):29-40. PubMed ID: 1898612
[TBL] [Abstract][Full Text] [Related]
11. Chemokines of the alpha, beta-subclass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1.
Kuna P; Reddigari SR; Rucinski D; Schall TJ; Kaplan AP
J Allergy Clin Immunol; 1995 Feb; 95(2):574-86. PubMed ID: 7531729
[TBL] [Abstract][Full Text] [Related]
12. Histamine and sulfidoleukotriene release from human basophils: different effects of antigen, anti-IgE, C5a, f-Met-Leu-Phe and the novel neutrophil-activating peptide NAF.
Dahinden CA; Kurimoto J; Baggiolini M; Dewald B; Walz A
Int Arch Allergy Appl Immunol; 1989; 90(2):113-8. PubMed ID: 2479603
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mediator release by human basophils: importance of the sequence and time of addition in the combined action of different agonists.
Dahinden CA; Bischoff SC; Brunner T; Krieger M; Takafuji S; de Weck AL
Int Arch Allergy Appl Immunol; 1991; 94(1-4):161-4. PubMed ID: 1718886
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils.
Botana LM; MacGlashan DW
J Leukoc Biol; 1994 Jun; 55(6):798-804. PubMed ID: 7515096
[TBL] [Abstract][Full Text] [Related]
15. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.
Kurimoto Y; De Weck AL; Dahinden CA
Eur J Immunol; 1991 Feb; 21(2):361-8. PubMed ID: 1705512
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
[TBL] [Abstract][Full Text] [Related]
17. The role of basophils in allergic disease.
Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
[TBL] [Abstract][Full Text] [Related]
19. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
20. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils.
Kuna P; Reddigari SR; Schall TJ; Rucinski D; Viksman MY; Kaplan AP
J Immunol; 1992 Jul; 149(2):636-42. PubMed ID: 1378073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
